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THE PERSISTENCE AND SECONDARY POISONING RISKS OF SODIUM 
MONOFLUOROACETATE (1080), BRODIFACOUM, AND CHOLECALCIFEROL IN 
POSSUMS 
C. T. EASON, G. R. WRIGHT, and L. MEIKLE, Manaaki Whenua - Landcare Research, P.O. Box 69, Lincoln, 
New Zealand. 
P. ELDER, Steroid and Immunobiochemistry Unit, Christchurch Health Laboratories, Christchurch Hospital, P.O. Box 
151, Christchurch, New Zealand. 
ABSTRACT: To determine the risk of secondary poisoning for animals preying on sub-lethally poisoned brushtail 
possums, captive possums were treated with near-lethal doses of sodium monofluoroacetate (1080) or brodifacoum, and 
toxicant concentrations in blood and tissue were monitored over time. Sodium monofluoroacetate was rapidly eliminated 
from the blood (within three days). Brodifacoum was retained in the liver and, to a lesser extent, the muscle of possums 
for eight months after dosing. To determine the potential risk for animals scavenging on the carcasses of possums 
poisoned with cholecalciferol, cats were fed poisoned carcasses for six days. No changes in behavior, appetite, or body 
weight were observed. Serum calcium concentrations increased slightly, but remained within the normal range for cats. 
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INTRODUCTION 
Sodium monofluoroacetate (1080) has been used for 
vertebrate pest control in New Zealand since 1954. It is 
currently used most frequently in aerially sown baits and 
in baits in bait stations for the control of the Australian 
brushtail possum (Trichosurus vulpecula) (Livingstone 
1994). The use of 1080 has been largely restricted to 
authorized wildlife management staff within the 
Department of Conservation and licensed operators within 
regional councils. In recent years, community groups, 
farmers and hunters have become more involved in 
possum control, and alternatives to 1080 that can be used 
without special permits have been sought. This need has 
led to the registration of brodifacoum (Talon~) in 1991 
and cholecalciferol (CAMPAIGN*) in 1995, and these two 
poisons are now playing an increasingly significant role in 
possum control. 
An important consideration when using any vertebrate 
pesticide is the risk of secondary poisoning. Secondary 
poisoning can be in two forms: from non-target animals 
scavenging poisoned possum carcasses, or from animals 
preying on live possums that have the pesticide in their 
tissues but have not received a lethal dose. Humans also 
occasionally harvest possums for food. 
Dogs are particularly susceptible to secondary 
poisoning with 1080 (Eason et al. 1994a). Analyses of 
1080 concentrations in rabbit carcasses have shown that 
there is a substantial decrease in 1080 in muscle, liver, 
and kidney during the first three weeks after death 
(Gooneratne et al. 1994). However, recent analyses of 
residue in possum carcasses after a control operation have 
shown that 1080 can persist in tissues in amounts that 
would be lethal to dogs for at least two to three months 
(Meinken, pers. comm.), even though the carcasses had 
substantially decomposed over this period. As for 1080, 
the secondary poisoning risks from brodifacoum-
contaminated carcasses are well known (Eason and Spurr 
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1995), and toxic amounts of brodifacoum may be retained 
in a carcass. 
The existence of an effective antidote to brodifacoum 
in the form of vitamin Kl means that dogs that have eaten 
carcasses containing brodifacoum residues can usually be 
saved. Unfortunately, there are no consistently effective 
antidotes for 1080 poisoning. 
In contrast, studies of dogs fed rats poisoned with 
cholecalciferol suggest that the risk of secondary 
poisoning with this pesticide is low (Marshall 1984). 
However, these data may not be directly applicable to 
possums, since higher concentrations of cholecalciferol 
are used in possum baits (0.83) compared with rat baits 
(0.0753) which may lead to higher residue levels in the 
possum carcasses. 
In this paper persistence data is reported which may 
be used to assess the magnitude and duration of the risks 
of secondary poisoning of animals preying on live 
possums which have been sub-lethally dosed with 1080 or 
brodifacoum. In addition, preliminary tissue residue 
results are reported in possums, and feeding study data 
from cats fed possums that have been poisoned with 
cholecalciferol. 
METHODS 
Determining the Persistence of Sub-lethal Doses of 
Brodifacoum and 1080 
A stock solution of brodifacoum was obtained from 
ICI Crop Care, Richmond, New Zealand and 1080 
powder from Animal Control Products, Wanganui, New 
Zealand. Groups of six possums (three male and three 
female) were orally dosed with 0.1 mg/kg (2 ml/kg of a 
0.05 mg/ml solution) of either brodifacoum in propylene 
glycol or 1080 in distilled water. The animals were 
allowed free access to food and water before dosing. 
These doses were equivalent to a possum eating 10-20 g 
of Talon* cereal baits containing 20 ppin brodifacoum, 
or approximately 0.5 g of cereal bait containing I080 
at 0. 08 3 . Earlier studies have demonstrated that 100 to 
200 g of Talon~ bait or 5 to 10 g of 1080 bait would be 
sufficient to kill most possums (Eason et al. 1994a). A 
series of blood samples were taken from the jugular vein 
of each possum before and after dosing. Samples were 
taken at 0.5. 1, 1.5, 2, 3, 4, 8, 12, 24, 48, and 96 hr 
after dosing with I080, and at 4, 8, 24, and 48 hr and 7, 
14, 21, 28, and 35 days after administration of 
brodifacoum. 
Previous studies in laboratory animals and sheep 
demonstrated that concentrations of I080 in blood exceed 
those in tissue (Eason et al. 1994b). Thus, tissue samples 
were not taken for I080 analysis. since concentrations in 
the blood provide a worst-case persistence profile. By 
contrast, experiments in rats and sheep have shown that 
higher concentrations of brodifacoum in tissues 
(particularly the liver) exceed blood concentrations (Laas 
et al. 1985). Hence, a further 32 possums were randomly 
divided into groups of four animals each (two male and 
two female) . One group was killed before dosing and the 
other seven groups at 2, 7, 14, 35, 64, 126 or 256 days 
after dosing with brodifacoum at 0.1 mg/kg. Muscle 
tissue and liver samples were collected at post-mortem. 
All plasma and tissues were stored at -20°C for later 
analysis. Brodifacoum was analyzed by high-performance 
chromatography with fluorescence detection using 
published methods of determining the compound in blood 
(Kelice and Murphy 1989) and animal tissues (Hunter 
1983). A gas-chromatography technique with electron 
capture detection was used to measure the dichloroaniline 
derivative of 1080 (Eason et al. 1994b). 
The Persistence of Cholecalciferol in Possums 
A stock solution of cholecalciferol was obtained from 
AgrEvo, Pennants Hill, Sydney, Australia. Thirteen 
possums were randomly divided into two groups and 
orally dosed with 20 mg/kg (2 ml/kg of a IO mg/ml 
solution) of cholecalciferol diluted in com oil. A dose of 
20 mg/kg cholecalciferol would be equivalent to a possum 
eating approximately IO g of cereal bait containing 
cholecalciferol (0.83) which would be a lethal or near-
lethal dose for most animals. Serial blood samples were 
taken from three cholecalciferol-treated animals 
immediately before and at 3, 6, 9, 12, 17, 23, and 29 
days after dosing. At 3 and 29 days after dosing, the 
remaining ten possums were killed and samples of heart, 
kidney, liver. abdominal fat, and femoral muscle tissues 
were collected. 
In order to gain biological activity, cholecalciferol 
(Vitamin D3) must undergo metabolic conversion to 25-
hydroxy vitamin D (250HD), a major active metabolite 
(Keiver et al. 1988). Concentrations of 250HD were 
measured in possums after exposure to cholecalciferol as 
an indication of vitamin D status. A radioimmunoassay 
(Amersham International Ltd, Amesham, UK) based on 
competition between unlabelled and tritium-labelled 
250HD for binding to the 25-hydroxy vitamin D binding 
protein from rickettic rat serum was used to determine 
250HD concentrations. As with the 1080 and brodifacoum 
experiment, all possums were allowed free access to food 
and water before and after dosing, and plasma and tissue 
samples were stored at -20°C before analysis. 
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Secondary Poisoning Feeding Studies 
Twelve feral cats were exclusively fed whole 
cholecalciferol-poisoned possum carcasses for five days. 
Appetite and body weight were monitored daily, and 
blood samples were taken for serum calcium 
measurements at regular intervals. 
RESULTS 
Determining the Persistence of Sub-lethal Doses of 
Brodifacoum and 1080 
No differences were detected between the results from 
male and female possums, so the data were combined. 
Sodium monofluoroacetate was rapidly absorbed into the 
blood and remained at peak concentrations (i.e., > 1 
µg/ml) for 0.5 to 8 hr after dosing. By 24 hr after 
dosing, plasma concentrations had decreased to 0.025 
µglml. Trace amounts (0.006 µg/ml) were detected at 48 
hr after dosing. No 1080 could be detected in the blood 
96 hr after dosing (Figure 1). By contrast, peak plasma 
concentrations (i.e., >I µg/ml) of brodifacoum occurred 
in possums between 24 and 48 hr after dosing, and trace 
amounts could still be detected in the blood of some 
possums 21-28 days after dosing (Figure 2). 
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Figure l. Concentrations of 1080 (µg/ml ± SE) in possum 
plasma after oral administration of 0.1 mg/kg. 
Persistence of brodifacoum in the liver and muscle 
differed markedly from persistence in the blood. 
Measurable concentrations were found in the liver 254 
days after dosing. Considerably lower concentrations 
were also found in the muscle tissue (Table 1). 
The Persistence of Cholecalciferol in Possums 
Concentrations of 250HD in plasma increased from a 
mean of 39.6 ng/ml before dosing to a mean of 949 
ng/ml six days after exposure, and subsequently declined 
to approximately 600 ng/ml by 29 days post-dosing 
(Figure 3). 
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Figure 2. Concentration of brodifacoum (µg/ml ± SE) in 
possum plasma after oral administration of 0.1 mg/kg. 
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Figure 3. Concentrations (µg/ml ± SE) of 25-hydroxyviwnin 
D (250HD) in possum plasma after oral administration of 20 
mg/kg cholecalciferol. 
Table 1. Mean brodifacoum concentrations in possum muscle, liver, and plasma after oral administration of 
0.1 mg/kg to each group (n=4). 
Time in days Concentrati9n (µgig or µ.g/ml ± SE) 
after dosing 
Liver 
2 0 .177 (0.011) 
7 0.119 (0.009) 
14 0.100 (0.032) 
35 0 .095 (0.023) 
63 0.109 (0.024) 
126 0.075 (0.029) 
254 0 .085 (0.009) 
Concentrations of 250HD in heart, kidney, liver, and 
fat ranged from 40 to 60 ng/g 3 days after dosing, and 
appeared to decrease in all tissues with the exception of 
fat during the following 4-week period (Figure 4). As 
with the 1080 and brodifacoum studies, sample siz.e was 
not adequate to detect any sex difference so the data from 
both sexes were combined. 
Secondary Poisoning Feeding Studies 
Each of the 12 cats ate approximately 1 kg of possum 
carcasses containing residues of cholecalciferol over the 
five-day period. At the end of five days mean serum 
calcium concentrations were slightly elevated compared to 
pre-treatment levels, but remained close to the normal 
range for cats (2.0-2. 7 mmol/L). Calcium concentrations 
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Muscle Plasma 
0.016 (0.001) 0.118 (0.021) 
0.011 (0.007) 0.034 (0.009) 
0.011 (0.000) 0.004 (0.003) 
0 .010 (0.002) 0 .002 (0.002) 
0 .008 (0.001) 0.000 (0.00) 
0 .009 (0.002) 0.000 (0.00) 
0 .007 (0.002) 0.000 (0.00) 
declined to baseline levels by 12 days post-dosing (Table 
2). Appetite and body weight of the cats were not 
affected (Figure 5). 
DISCUSSION 
After oral administration of sub-lethal amounts of 
1080 to possums, 1080 was rapidly absorbed and 
subsequently eliminated from the plasma. These results 
in possums are consistent with our early results in 
livestock (Eason et al. 1994b) and rabbits (Gooneratne 
et al. 1995), and studies in mice which show rapid 
elimination of 1080 (Sykes et al. 1987). 
For livestock suspected of near or sub-lethal exposure 
to 1080, it has been suggested that an adequate margin of 
safety (for avoiding residues in food) would be achieved 
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Figure 4. Concentrations (µg/ml ± SE) of 25-hydroxyvitamin 
D (250HD) in possum tissue 3 (n=7) and 29 days (n=3) after 
oral administration of 20 mg/kg cholecalciferol. 
Table 2. Mean serum ca++ (± SE) concentrations in cats. 
Pre-treatment After 5 Days 
2.54 (0.06) 2.75 (0.10) 
by imposing a minimum withholding period of five days. 
Should a death in a flock or herd be attributed to 1080, 
the withholding period should be doubled to ten days for 
the surviving stock and the livestock removed to a 1080-
free pasture (Rammell 1993). The results would indicate 
that a similar safety margin of at least ten days after baits 
have been removed or decomposed would be appropriate 
for possum to ensure that residues are not present in meat 
harvested for human consumption. It is apparent that 
there is a contrast between the persistence in living 
animals which have received a sub-lethal dose of 1080 
versus the persistence of 1080 in carcasses. 
This is not the case with brodifacoum, where 
persistence in possums is probable in both lethally and 
sub-lethally poisoned animals. This remarkable 
persistence highlights the potential secondary and tertiary 
risks associated with brodifacoum when used for possum 
control. For example, feral pigs will scavenge possum 
carcasses and it is apparent from this study that possums 
dying up to eight months or more after being exposed to 
brodifacoum may contain residues that could be 
transferred to pigs. As feral pigs are bunted as a food 
source in New Zealand, there is at least a theoretical risk 
of tertiary poisoning of humans long after the use of 
brodifacoum has been discontinued in a panicular area. 
A sensible precaution would be to recommend that the 
livers from all game be discarded, since much higher 
concentrations occur in the liver than in muscle or blood. 
Even if residues in most animals never reached levels 
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Figure 5. Mean bodyweight (kg ± SD) in cats before. during, 
and after feeding on the carcasses of cholecalciferol-poisoned 
possums. 
1 Week Later 7 Weeks Later 
2.72 (0.07) 2.64 (0.03) 
capable of causing serious harm to meat-eaters, the 
presence of brodifacoum in any meat could be a concern 
to the public. The presence of brodifacoum in possum 
carcasses is also likely to pose a hazard to predators such 
as barrier hawks, as well as farm dogs. 
The preliminary results with cholecalciferol indicated 
that elevated concentrations of 250HD were present in 
possum carcasses, and that they were likely to persist for 
several weeks in animals that had received sub-lethal 
doses. In comparison to other examples in the literature, 
the clearance of elevated 250HD in poisoned possums 
appeared to be quite slow. This is perhaps not surprising 
since it has been shown in other animals that clearance of 
250HD is dose dependent (Keiver et al. 1988), and 
possums in the present study received extremely high 
near-lethal doses. For example, the plasma elimination 
half lives of 250HD were 15 to 36 days in humans when 
vitamin D status was normal, but increased to 25 to 68 
days in humans and cows experiencing vitamin D 
toxicosis (Keiver et al. 1988). 
The feeding study of cats appeared to confirm earlier 
work with dogs (Marshall 1984) which indicated that the 
risk of secondary poisoning with cholecalciferol is low. 
This is despite the presence of elevated concentrations of 
250HD in possum carcasses. Research in rats has 
demonstrated that 250HD is active when administered 
orally (Rambeck et al. 1990), but is partially degraded in 
the intestinal tract (Frolick and Deluca 1971). Hence, 
some degradation of 250HD in possum meat by cats 
during digestion probably protects them. Further studies 
are planned with dogs to confirm the findings with cats, 
since it is believed that the data suggests a low risk, but 
not no risk, of secondary poisoning. 
Even in the absence of this additional data, it is 
apparent thaf the risks of secondary poisoning with 
cholecalciferol are low when compared with brodifacoum 
or 1080. Dogs and cats only need to eat a very small 
portion of a possum carcass poisoned with 1080 to receive 
a lethal dose, and pets or farm dogs could not feed 
exclusively on possum carcasses containing 1080 for 
brodifacoum for 5 days without becoming ill or dying. 
Nevertheless, all pets and farm dogs should be 
discouraged from eating animals that have been poisoned 
with cholecalciferol, even if the risk of secondary 
poisoning is perceived to be low. based on currently 
available evidence. 
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